Reddit Posts
VTGN (Q1 Phase 3 Topline results expected for Fasedienol)
$VTGN appears likely to bounce nicely - Cash on hand and many options in the pipeline
$VTGN likely to bounce nicely - Cash on hand and many options in the pipeline
VTGN Incoming catalysts- bears are pushing hard but have been beaten back so far
Anti-aging and life expectancy companies
VTGN Incoming - 4Q Catalyst
VTGN has a Phase 3 readout in 4Q25 - Already worked once
$VTGN β A Mental Health Company You Might Not Know About
$VTGN β A Mental Health Company You Might Not Know About
$VTGN β A Mental Health Company You Might Not Know About
Recent developments and Yahoo Finance news on my small-cap biotech stock to watch.
A soft catalyst on my biotech small-cap might still make a hard move
A Catalystic development surrounding my biotech small-cap to watch
Biotech's Been Ice Cold β But One Stock Surges on FDA Approval, Another Shows Subtle Strength
Biotech's Been Ice Cold β But One Stock Surges on FDA Approval, Another Shows Subtle Strength
Biotech's Been Ice Cold β But One Stock Surges on FDA Approval, Another Shows Subtle Strength
Latest TA Breakdown on a new biotech small-cap
Pivoting back to a different small-cap in the biotech sector...
Upside momentum as of late has my eyes pivoted to another Biotech Small-Cap
$VTGN: Nearing All-Time Lows, But Cash Position Remains Strong
$VTGN: Nearing All-Time Lows, But Cash Position Remains Strong
Halt Trade Strategies Discussion (example, VTGN)
Pre-Market, Low Float, Small Cap - Event-Driven Strategy
Cing didnβt got run on positive phase-3 but VTGN run on Successful Fasedienol Trial
$SILO COULD BE THE NEXT $VTGN
VistaGen Therapeutics ($VTGN): A 3,471% surge unveiled - Discover the driving forces behind the explosive growth.
$SILO is working in the same Social Anxiety Disorder pace at $VTGN
Biotech on the Run: $VTGN. $SILO is on watch for similar biotech focus.
$VTGN Reacting to Good News Today, $SILO is a similar Biotech
$VTGN Reacting to Good News Today, $SILO is a similar Biotech
$VTGN is Soaring over 850% and $SILO is in the same Biotech Space.
VTGN (2.11->57.97->11.45 so far today)
VTGN is starting 2023 off with a BIG BANG!!
$SMMT, $VTGN--Pre-market Biotech Movers on News
$VTGN ramping up for a run???
Vistagen Therapeutics $VTGN proceed with the Phase 3 clinical trial of PH94B an acute treatment of anxiety in adults with SAD
All BBBY bag holders⦠dump it into $VTGN
$VTGN 600,000 CEO insider buys. πππͺπΉπ€π₯π₯π. $BBBY $GME $NVAX $PFE $GOVX app.quotemedia.com/data/downloadFβ¦
$VTGN FDA Fast Track Designation Granted
βͺ $VTGN MONDAY TO THE MOON The company is evaluating potential study design modifications in the PALISADE Phase 3 program, including extended exposure periods,and is preparing to meet with FDA to discuss potential next steps for late-phase clinical development of PH94B.β¬
$VTGN Phase 3 clinical trial Announced after market close of process consultation with FDA PALISADE-1 Imperfect PALISADE-1 Imperfect PALIS 9 Pre-Effect. Severe serious condition with PALISADE-1 or clinical PH 94B. In addition, the company evaluated the score of 200PALISADE
Does anyone have any information on VTGN?
To everyone who hated VTGN we are now green!
VTGN is on its way back! We will hit 0.25 at close. π
Last but in opportunity for VTGN!
VTGN to the moon tomorrow!
VTGN! Going to the moon tomorrow!
VTGN looks like a great play! Canβt wait for the morning!
VTGN as of 2022, phase 3 results this year for PH94B
VTGN - Riding the Wave before a PR.
VTGN made the list from the first article in this feed post
VTGN drug will replace benzodiazepines soon...
The penny stocks that are buys right now in the biopharmaceutical industry
VTGN gets $9 PT from Baird, calls stock "significantly undervalued."
VTGN gets $9 PT from Baird, calls stock "significantly undervalued."
Help me do DD on Vistagen Therapeutics (VTGN)
Mentions
Also VTGN is gaining momentum, somebody watching?
Premarket watchlist : **$WOK** : China, known runner, bottomed out. **$VMAR** : Closing of public offering : https://finviz.com/news/258950/vision-marine-technologies-inc-announces-closing-of-public-offering Short week ahead scope: **$EONR** : USA seized third Venezuela tanker, escalating tensions: https://abcnews.go.com/amp/US/us-seizing-ship-caribbean-sources/story?id=128583966 **$SIDU** : first mentioned this couple weeks ago, underdog imo, NASA subcontractor, Dec 10: Successful bus-level commissioning of LizzieSat-3 (3D printed + Al-enhanced). The tech is officially operational in orbit. 40% on Friday climbing. **$OTLK** : dips below $2, still a risky play, catalyst anytime now. **$VTGN** : still in for correction.
I personally think that VTGN will continue its recovery today, albeit with less volume & volatility. I think anyone that bought in at yesterday's highs will have the opportunity to exit over the next week (if not today if the volume comes in). NFA
everyone I was hyping a sketch biotech company all year called VTGN. I was up 60k when I woke up this morning then ooof. RIP my gains and some.
So holding VTGN into power hour 
YCBD triangle break now VTGN cup and handle. bullish signals getting abandoned and/or rejected left and right what's going on 
What are we doing with VTGN? Holding into AH?
VTGN is a dangerous play going into power hour. We think it will recover but could also be a major sell of at the end of the day. Any big players will have waited the day for the recovery before cutting ties. Could also finally run up above $1. Could go either way, but I would set a stop loss.
VTGN for the bounce back, tp at 1.1
VTGN is going to pull another RZLT, totally oversold and it's a great buy right here. There last report doesn't mean much
VTGN holding 62.786M just in cash. Almost 40% of their market cap
VTGN not only do they have cash but other stuff in the pipeline at phase 2. No brainer entry for me here with a 20% SL
Slapped VTGN due to its cash value
Called VTGN out ur for yall if it holds 1$ if it reaches today itβs good to enter I believe
VTGN inching its way back up
Again leaving it here for a quick swing still time to enter VTGN
$VTGN bouncing and will run.. check out cash on hand over $1.50 and many options in the pipeline
$VTGN has cash on hand greater than $1.. not to mention the ph 2 trials and assets.. Watch for a likely bounce here
I got burned bad by VTGN
RIP VTGN. About to drop to under $1
Just waiting on VTGN to drop news any day now for palisade3
Looks like VTGN might be a dud
!banbet $VTGN 5.00 14d
I love how my sketchy biotech investment VTGN is ripping this week while all my smart investments have me dive bombing - looking at you HOOD β οΈ
Also how fucking long do I hold speculative biotech stock. Up like 60% on VTGN.
VTGN. but its on the verge of leaving penny land. 2 catalysts coming up. one before EOY and the other first half of 2026.
Good callout, are you still holding VTGN aswell?
Also just noting that VTGN is expected to release phase 3 results for an on going clinical trial called palisade 3 Sometime in Q4 of 2025.
If you boys and girls want a wild ride in biotech. Look at VTGN. I know some people with massive positions and if the results read out positive in November on their drug. Rocket 400% to 1200%
Regards want to play? VTGN releases results at the end of this month. Coin flip. If results are a repeat of their prior results this will rocket. If not youβll lose 80%
Janus Henderson, 13.6% stake in $VTGN. BOOM \- [https://www.barchart.com/story/news/35067285/janus-henderson-just-took-a-13-6-stake-in-vistagen-should-you-buy-vtgn-stock-now](https://www.barchart.com/story/news/35067285/janus-henderson-just-took-a-13-6-stake-in-vistagen-should-you-buy-vtgn-stock-now)
Man, I love your energy here. VTGN has real potential, no doubt. The key is to treat plays like this as seeds, not lottery tickets. Even if the next data readout goes your way, the real wealth comes from repeating this process, researching deeply, sizing smartly, holding with patience. One big win is nice, but a lifetime of disciplined investing is how you change your future. Keep building, keep learning, and donβt lose sight of the bigger picture.
VTGN. 2 clinical trials both in phase 3 with results in q4 2025 and first half of 2026. made around 300% last time they announced positive results in 2023
Do less - buy NVDA, AMD, SOFI, VTGN, META, GOOG
KLAR? only 10 shares. Im still relatively new and this is my first time getting an IPO. But not really a penny stock. VTGN im at 500 at 3 but I want more so ill probably avg up
What abaout SCYX and VTGN ?
VTGN for me, been in this one for a long time and they have 2 ongoing clinical trials both in phase 3 with results expected q4 2025 and first half of 2026. possibility of a NDA if both have positive results.
Any thoughts on VTGN? Been in this one for a while, earnings report on the 7th AH and 2 potential upcoming catalysts. 1 in q4 this year and 1 in the first half of 2026.
Bought 600 shares of VTGN. Long term
I am VTGN at 2.06. I will probably buy more if it falls 2 or lower. I have seen it hit over 2.60 since I have held it. This is a long hold for me. I am going to hold it until 2026 when most of the clinical trials end. If it goes over 3 in 2025, I might sell it, but that's not the end goal.
Any views on VTGN calls
Hey, love this breakdown β thanks for bringing $VTGN back on the radar! That fasedienol angle is interesting, especially the part about non-sedative, fast-acting treatment for Social Anxiety Disorder. A couple quick questions though: * Did they share any new data on efficacy or just reiterate prior findings at the ADAA conference? * Do you know where they are in the FDA timeline β are we expecting Phase 3 readouts soon or still in mid-stage? * Any word on how they plan to commercialize fasedienol if approved β partner, go solo, or license it out? Also, out of curiosity, how do you think $VTGN stacks up right now against some other CNS/mood-focused names like: * **$MNMD (MindMed)** β Also targeting anxiety but with a psychedelic pipeline (MM-120 for GAD). Higher risk, but also drawing attention for novel mechanisms. * **$AXSM (Axsome Therapeutics)** β Their AXS-05 (approved for depression) gives them a revenue-generating foothold while they explore more indications. Stronger fundamentals but less upside room maybe? * **$PRAX (Praxis Precision Medicines)** β A bit broader in CNS but working on fast-acting neuropsychiatric therapies. Similar to $VTGN in trying to fill unmet needs but still in development phase for most.
Hey, love this breakdown β thanks for bringing $VTGN back on the radar! That fasedienol angle is interesting, especially the part about non-sedative, fast-acting treatment for Social Anxiety Disorder. A couple quick questions though: * Did they share any new data on efficacy or just reiterate prior findings at the ADAA conference? * Do you know where they are in the FDA timeline β are we expecting Phase 3 readouts soon or still in mid-stage? * Any word on how they plan to commercialize fasedienol if approved β partner, go solo, or license it out? Also, out of curiosity, how do you think $VTGN stacks up right now against some other CNS/mood-focused names like: * **$MNMD (MindMed)** β Also targeting anxiety but with a psychedelic pipeline (MM-120 for GAD). Higher risk, but also drawing attention for novel mechanisms. * **$AXSM (Axsome Therapeutics)** β Their AXS-05 (approved for depression) gives them a revenue-generating foothold while they explore more indications. Stronger fundamentals but less upside room maybe? * **$PRAX (Praxis Precision Medicines)** β A bit broader in CNS but working on fast-acting neuropsychiatric therapies. Similar to $VTGN in trying to fill unmet needs but still in development phase for most.
I thought $VTGN was drawing dead but the higher lows in the last couple weeks brought me back to it. Break through $2.30 would be huge
Agree, VTGNβs nasal spray pherine platform potentially can be first-in-class drugs for social anxiety disorder, MDD, and post-menopausal hot flashes. These conditions are demanding novel, more effective, safer drug options.
VTGN actually [developed the first drug to show positive Phase 3 data for acute treatment of Social Anxiety Disorder](https://beyondspx.com/article/vistagen-therapeutics-inc-nasdaq-vtgn-pioneering-neuroscience-with-promising-pherine-candidates). Their nose-to-brain pherine tech hits different - no systemic absorption needed like traditional meds. Got $119M cash to burn through trials too, not some penny stock pump n dump bs.
Hmm Iβll take a look. That one has definitely been talked about before I bet you could find something in this sub if you look up VTGN in the Reddit search bar
Check out VTGN. Do some DD for them as well?
Biotech plays are like playing Russian roulette with five bullets in the chamber - but at least these aren't another garbage AI stock pump. VTGN's nasal spray for social anxiety reminds me of the time I tried to cure my portfolio anxiety by snorting pre-workout powder at market open.
Biotech plays are like throwing darts at a board while blindfolded and drunk - except VTGN's [74.7M cash runway](https://finance.yahoo.com/quote/VTGN/balance-sheet?p=VTGN) means they're at least using premium darts while burning money on nose sprays that make you less awkward at parties.
Got into VTGN as well. Thanks folks. Looks legit and looks like a runner. I believe I am late to AUUD now so picking the next best winner
VTGN $2 puts 1/16/26 look chill q
VTGN, beaten down pharmaceutical company, if they can pass the upcoming FDA phases itβd expected to reach $14a share current $3
VTGN next year is going to pop off
Innovation and development; $VTGN was overvalued in the past for sure, but now you can easily make the argument their beyond undervalued.
VTGN. New social anxiety medication followed by many more. In the form of a nasal spray. First in it's class. Waiting for this one to blow up. Don't think there has been a new anxiety medication in years. It's seems to dodge the bad side effects of current anxiety medication directly through the nasal passage. Currently at the end of phase 3
Only down 15% with AKBA? I also have FGEN, PALI, and VTGN.
Check out VTGN, anxiety/depression nasal spray⦠bruh
VTGN. Making a new class of drug. Nasal spray for Social anxiety. Endless potential if it goes well. Currently phase 3 and fast tracked by the FDA
Vistagen $VTGN up pre market on positive Phase 2A trials
So much long term potential as well. Big things coming to VTGN
VTGN looks like itβs gearing up for a run
For a penny stock to get a decent run one of four things has to happen from my experience. 1- itβs rigged by mms and run up before an offering. This is usually the case in low floats or sometimes used to get to warrants that someone needs to cash in.. (CXAI is a good example).. 2- high short interest enough to get the attention of the rest of the market (TRKA GNS WHLR examples of this) 3- biotech phase 1,2 or 3 with amazing results in cancer or Alzheimerβs or another area with little to no effective treatments) ie TTOO VTGN SAVA etc) 4- expected large catalyst like Fda approvals Buyouts mergers buybacks big earnings ect NVOS TRKA ect and the best will fit into several of these categories.. high short interest low float big catalysts.. MCOM- stocks like this one that have had a ton of dilution end up leaving a bad taste for investors.. a stocks history and float size are important factors. Now could some discord come along and try and make some money off of it and have it run a couple cents.. sure but I canβt see myself any reason for the stock to go anywhere, but down and be reverse split. This is not financial advice but if I were you, I would be looking for a recent reverse split with a relatively low float under 5 million that has an upcoming catalyst and a decent amount of cash on hand so you donβt get stuck in an offering.. Research patience timing.. all extremely important. Small caps have been decimated over the last few years and things. Donβt look to be getting any better anytime soon. These are not long holds unless you wanna lose every cent you got. In and out done.
VTGN around .80c and sold around $13
If this stock even has a fraction of the squeeze that VTGN has I'm gonna make $10 million. I might get 2 Lambos! 1 for each middle finger!
Press Release: Vistagen To Report First Quarter Financial Results and Host Corporate Update Conference Call on August 10, 2023 5:19 pm ET August 8, 2023 (Dow Jones) Print Vistagen To Report First Quarter Financial Results and Host Corporate Update Conference Call on August 10, 2023 SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--August 08, 2023-- Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, today announced it will host a conference call and webcast on Thursday, August 10, 2023, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to provide a corporate update and report results for its fiscal year 2024 first quarter ended June 30, 2023. Event: Vistagen Fiscal Year 2024 First Quarter Corporate Update Conference Call Date: Thursday, August 10, 2023 Time: 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) US Dial-in (Toll-free): 1-800-954-1051 TOLL/International Dial-in: 1-212-231-2924 Conference ID: 22027732 Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1627439&tp_key=9f0f4cb009
Kind of disappointed with paper hands here trying to make a quick buck out of TTOO. Iβve been making 5-10K from NKTR fluctuations every day, but not even touching TTOO despite $50-60L swings on profit every hour. Itβs a bigger game. If and when the FDA approval comes through, I wouldnβt be surprised to see a VTGN repeat. As soon as TTOO goes down .2-3 cents, people start bringing up random stocks to confuse people. People whoβve existed TTOO during dips, I donβt think itβs still late to get back in. PS: Itβs not a financial advise. Use your own judgement.
Probably. But with a moated technology, and I would think consistent sales of these test kits that go with them, I can sell half for profit above 1, go long with the other half. Iβm out of my element with biotech, so Iβm using TA to guide me here. Pissed off I missed out on being screwed by the market halt on $VTGN, wanted something to complain about this week π€ͺπ€£
24.00? Are you talking about VTGN?
They have very different products. CING is developing a drug for ADHD. AFAIK VTGN is developing a drug for Social Anxiety with Major Depressive Disorder.
Just yesterday, when VTGN made a 3000% move premarket, Robinhood randomly stopped allowing trades on it while it was still going up. Because Citadel was getting smashed on their short positions. But the regards in here won't get that. They pretending that a broker having a conflict of interest with their clients is some sort of conspiracy theory rather than standard practice π€£π€£π€£ They belong here...
Yes, Thwitter is absolutely right. Medical stocks rely heavily on catalysts. Not only is TTOO waiting on FDA approval but itβs also the only device of its kind. Crazy enough to see a company (VTGN) that created a nasal drug for social anxiety shoot up 3000% so that is proof of potential.
$SILO Reaches Positive Milestone with Nasal Formulation of SPC-15 For Anxiety, PTSD, and Stress-Related Disorders π $VTGN ran 1000% yesterday on positive dataβ¦$SILO could be next up. Read news here: [https://ir.silopharma.com/single-news-releases/?webmasterId=104586&qmodStoryID=5435610220877266](https://ir.silopharma.com/single-news-releases/?webmasterId=104586&qmodStoryID=5435610220877266)
In recent years, psychedelic drugs have become more common in pipelines trying to develop treatment for crippling mental health conditions. I looked for companies developing treatments for MDD, SAD, PPD, and GAD. Some like $ATAI or $CMPS use shrooms, but ketamine has shown very promising effects in treating depression, especially treatment-resistant depression. I found $SEEL and $VTGN just searching for assets under proprietary formulation of ketamine. $SEEL uses a racemic ketamine while $VTGN is of the pherine family, so same receptor. They were both large gambles, so unfortunately I ended up only going with one
SEEL should have a nice pop in the future, but not anywhere near as much as VTGN. VTGN had a tiny float
Until it's not. Sometimes, you throw some lottos and this one is a solid one. Always risk. Anyway, congrats on VTGN.
Honestly, I'm hoping in the future $GSTC turns into a $VTGN. Still has a ways to go. But I was told about that, what a beauty.
TBH, I was a little worried about the earnings, but decided to hold because I believe itβs a longer term stock. The earnings have been much better than expected. So, the downside risk is quite limited at this point. It can only go up. $1 seems practical at this point! When the final FDA approval comes in, it could go VTGN route, and it does so, I am going take a month long vacation :) https://preview.redd.it/psy8z4lyfrgb1.jpeg?width=1170&format=pjpg&auto=webp&s=68dd9a4511fe6888fc6fbefd14ee92a5f344dbf0
Thanks, I was wondering why my response to the other VTGN thread was failing to post.
VTGN falling off a clif
This is now the VTGN Megathread. All others will be deleted. Thanks!